Aspen Aerogels (NYSE:ASPN) Updates Q1 2026 Earnings Guidance

Aspen Aerogels (NYSE:ASPN) issued an update on its first quarter 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of -0.280–0.240 for the period, compared to the consensus earnings per share estimate of -0.220. The company issued revenue guidance of $35.0 million-$40.0 million, compared to the consensus revenue estimate of $44.3 million.

Aspen Aerogels Trading Up 1.2%

NYSE ASPN opened at $3.58 on Wednesday. The firm’s fifty day moving average price is $3.32 and its 200 day moving average price is $5.10. Aspen Aerogels has a 12 month low of $2.80 and a 12 month high of $9.78. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.94 and a quick ratio of 3.33. The company has a market capitalization of $295.97 million, a price-to-earnings ratio of -0.96 and a beta of 2.99.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings results on Wednesday, February 25th. The construction company reported ($0.34) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.10). The company had revenue of $41.34 million during the quarter, compared to analysts’ expectations of $44.25 million. Aspen Aerogels had a negative net margin of 86.52% and a negative return on equity of 0.20%. Aspen Aerogels has set its Q1 2026 guidance at -0.280–0.240 EPS. On average, sell-side analysts expect that Aspen Aerogels will post 0.17 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Zacks Research raised Aspen Aerogels from a “strong sell” rating to a “hold” rating in a research report on Thursday, January 15th. Barclays decreased their price objective on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating for the company in a report on Friday, November 7th. Canaccord Genuity Group lowered their target price on shares of Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a research report on Friday, November 7th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $6.67.

Institutional Investors Weigh In On Aspen Aerogels

Several large investors have recently modified their holdings of the stock. Invesco Ltd. lifted its holdings in shares of Aspen Aerogels by 237.9% during the fourth quarter. Invesco Ltd. now owns 4,129,934 shares of the construction company’s stock worth $11,688,000 after purchasing an additional 2,907,558 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of Aspen Aerogels by 105.4% in the 2nd quarter. JPMorgan Chase & Co. now owns 1,246,506 shares of the construction company’s stock worth $7,379,000 after acquiring an additional 639,753 shares during the period. Goldman Sachs Group Inc. boosted its holdings in shares of Aspen Aerogels by 89.7% in the first quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock valued at $8,143,000 after acquiring an additional 602,586 shares in the last quarter. State Street Corp boosted its holdings in shares of Aspen Aerogels by 28.6% in the fourth quarter. State Street Corp now owns 2,501,469 shares of the construction company’s stock valued at $7,079,000 after acquiring an additional 556,833 shares in the last quarter. Finally, Millennium Management LLC increased its stake in shares of Aspen Aerogels by 59.6% during the third quarter. Millennium Management LLC now owns 1,447,517 shares of the construction company’s stock worth $10,075,000 after acquiring an additional 540,772 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.